Assembly Biosciences (ASMB) Financials: Revenue & Earnings

ASMB price $20.44 +0.14 +0.70%

Ticker
ASMB
Price
$20.44
Change
+0.14 +0.70%
Market cap ?
$416.23M
P/E ?
36.07
Dividend yield ?
0.00%
Beta ?
1.16
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
63
Value
42
Quality
48
Growth
100

Stocklytics score rationale: value 42, quality 48, growth 100.

Financials

2016201720182019202020212022202320242025
090187501480400015963000791050006254000071630002852000072303000

Assembly Biosciences, Inc. is a biotechnology firm in the clinical development phase, dedicated to identifying and advancing innovative therapeutic solutions for hepatitis B virus (HBV) infections within the United States. Its primary drug candidate, Vebicorvir, has successfully concluded Phase 2 clinical trials for individuals with chronic HBV. The company's development pipeline also features ABI-H3733, which has…

Fair value

ASMB fair value $21.50. Price $20.44. Price is about fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Compare ASMB

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—-0.66—9.07M
2026-08-13-0.20-0.7213.37M8.60M
2026-05-07-0.54-0.738.21M9.27M
2026-03-192.48-0.5142.46M7.42M
2025-11-10-0.72-0.5010.79M7.46M
2025-08-06-1.33-0.659.63M9.32M
2025-05-08-1.17-2.019.42M7.41M
2025-03-20-1.57-1.757.36M3.55M
2024-11-07-1.51-2.026.84M7.05M
2024-08-08-1.98-2.968.53M5.96M
2024-05-08-1.66-2.745.79M—
2024-03-27-2.15-2.887.16M—
2023-11-08-3.24-2.76——
2023-08-09-3.84-3.48——
2023-05-04-4.44-4.44——
2023-03-22-5.52-6.72——
2022-11-08-5.76-5.64——
2022-08-09-6.12-5.88——
2022-05-12-5.76-5.88——
2022-03-10-4.92-5.83—1.56M
2021-11-04-4.92-6.606.25M7.85M
2021-08-05-6.60-7.68——
2021-05-06-8.28-9.48——
2021-02-25-13.33-10.801.04M967.87K
2020-11-05-1.08-9.3634.61M288.43M
2020-08-052.28-0.3639.38M6.22M
2020-05-07-9.12-11.764.08M5.26M
2020-03-04-11.88-12.124.77M4.86M
2019-11-07-11.52-11.164.23M4.10M
2019-08-05-8.64-13.213.08M4.92M
2019-05-09-12.61-12.853.88M3.85M
2019-02-28-12.36-10.923.74M3.26M
2018-11-08-10.44-12.244.29M5.07M
2018-08-08-15.61-10.803.22M2.13M
2018-05-07-9.60-9.123.57M3.39M
2018-03-08-1.92-0.793.32M16.39M
2017-11-01-8.52-10.562.66M3.30M
2017-08-09-9.36-0.792.36M2.39M
2017-05-08-9.72-0.36684.37K25.19K
2017-03-02-8.04-0.67——

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-06-17Bjorkquist Jeanette MSell29$23.25674
2026-06-04McHutchison John GBuy8.00K$24.11192.88K
2026-06-04Mahony SusanBuy8.00K$24.11192.88K
2026-06-04Johnson-Pratt LisaBuy8.00K$24.11192.88K
2026-06-04Houghton MichaelBuy8.00K$24.11192.88K
2026-06-04Consylman GinaBuy8.00K$24.11192.88K
2026-06-04ALTIG ANTHONY EBuy8.00K$24.11192.88K
2026-05-26GILEAD SCIENCES, INC.Buy471.70K$26.5012.50M
2026-03-30Bjorkquist Jeanette MSell312$26.658.31K
2026-03-30Bjorkquist Jeanette MSell16$27.49440
2026-03-30White Nicole SSell188$26.655.01K
2026-03-30White Nicole SSell9$27.49247
2026-03-29Gaggar AnujBuy14.00K——
2026-03-29White Nicole SBuy14.00K——
2026-03-29Bjorkquist Jeanette MBuy3.50K——
2026-03-29Delaney William E IVBuy14.00K——
2026-03-29Okazaki Jason ABuy50.75K——
2026-03-29Bjorkquist Jeanette MBuy6.50K——
2026-03-29White Nicole SBuy26.00K——
2026-03-29Gaggar AnujBuy26.00K——
2026-03-29Delaney William E IVBuy26.00K——
2026-03-29Okazaki Jason ABuy94.25K——
2025-08-08GILEAD SCIENCES, INC.Buy2.30M$0.002.30K
2025-08-08GILEAD SCIENCES, INC.Buy1.15M$21.6024.80M
2025-08-08GILEAD SCIENCES, INC.Buy1.15M$21.6024.80M
2025-06-16Bjorkquist Jeanette MBuy300——
2025-06-16Bjorkquist Jeanette MBuy600$17.2410.34K
2025-06-05Houghton MichaelBuy3.50K$15.8155.34K
2025-06-05Mahony SusanBuy3.50K$15.8155.34K
2025-06-05McHutchison John GBuy3.50K$15.8155.34K
2025-06-05Johnson-Pratt LisaBuy3.50K$15.8155.34K
2025-06-05RINGO WILLIAM RBuy3.50K$15.8155.34K
2025-06-05ALTIG ANTHONY EBuy3.50K$15.8155.34K
2025-06-05Consylman GinaBuy3.50K$15.8155.34K
2025-03-31McHutchison John GSell757$9.857.46K
2025-03-31Bjorkquist Jeanette MSell180$9.851.77K
2025-03-31Okazaki Jason ASell355$9.853.50K
2025-03-31White Nicole SSell197$9.851.94K
2025-03-29Delaney William E IVBuy25.50K$10.62270.81K
2025-03-29Bjorkquist Jeanette MBuy1.66K——
2025-03-29Bjorkquist Jeanette MBuy1.90K$10.6220.18K
2025-03-29Okazaki Jason ABuy71.10K$10.62755.08K
2025-03-29White Nicole SBuy20.40K$10.62216.65K
2025-03-29Gaggar AnujBuy24.20K$10.62257.00K
2024-12-30Houghton MichaelBuy3.20K$15.6150.00K
2024-12-19GILEAD SCIENCES, INC.Buy940.50K$21.3720.10M
2024-11-25Schornstein AlexanderBuy5.00K$14.8574.25K
2024-11-25Schornstein AlexanderBuy2.98K$15.0044.64K
2024-11-22Schornstein AlexanderBuy17.02K$14.87253.10K
2024-11-18White Nicole SSell40$16.29652
2024-10-08Schornstein AlexanderBuy10.00K$14.58145.80K
2024-10-03White Nicole SSell157$14.812.33K
2024-10-03Okazaki Jason ASell197$14.812.92K
2024-08-02White Nicole SSell785$14.2311.17K
2024-08-02Okazaki Jason ASell981$14.2313.96K
2024-07-05Schornstein AlexanderBuy4.44K$12.5255.56K
2024-07-03Schornstein AlexanderBuy4.56K$12.2956.07K
2024-06-17GILEAD SCIENCES, INC.Buy179.50K$0.00180
2024-06-17GILEAD SCIENCES, INC.Buy179.50K$17.003.05M
2024-05-29Johnson-Pratt LisaBuy2.75K$15.0641.41K
2024-05-29McHutchison John GBuy2.75K$15.0641.41K
2024-05-29Mahony SusanBuy2.75K$15.0641.41K
2024-05-29Houghton MichaelBuy2.75K$15.0641.41K
2024-05-29Consylman GinaBuy2.75K$15.0641.41K
2024-05-29ALTIG ANTHONY EBuy2.75K$15.0641.41K
2024-05-29RINGO WILLIAM RBuy2.75K$15.0641.41K
2024-05-23Bjorkquist Jeanette MSell24$14.93358
2024-05-23McHutchison John GSell2.12K$14.9331.61K
2024-05-23White Nicole SSell172$14.932.57K
2024-05-23Okazaki Jason ASell549$14.938.20K
2024-04-30White Nicole SSell1.25K$12.7115.95K
2024-04-30Okazaki Jason ASell1.57K$12.7119.94K
2024-04-29White Nicole SBuy3.33K——
2024-04-29Okazaki Jason ABuy4.17K——
2024-04-29Delaney William E IVBuy3.33K——
2024-04-01McHutchison John GSell1.21K$13.0715.76K
2024-04-01Bjorkquist Jeanette MSell114$13.071.49K
2024-04-01White Nicole SSell197$13.072.58K
2024-04-01Okazaki Jason ASell354$13.074.63K
2024-03-29Bjorkquist Jeanette MBuy850——
2024-03-29Bjorkquist Jeanette MBuy1.55K$13.3020.61K
2024-03-29White Nicole SBuy17.50K$13.30232.75K
2024-03-29Delaney William E IVBuy20.00K$13.30266.00K
2024-03-29Okazaki Jason ABuy65.00K$13.30864.50K
2024-03-27Okazaki Jason ASell392$12.875.05K
2024-03-13Cook Robert Donald IIOther0——
2024-01-18Schornstein AlexanderBuy345.09K$0.80276.07K
2024-01-17Schornstein AlexanderBuy299.99K$0.78235.20K
2023-12-07Cihlar TomasOther0——
2023-11-21Schornstein AlexanderBuy100.00K$0.6766.70K
2023-11-20Schornstein AlexanderBuy300.00K$0.72215.40K
2023-11-17White Nicole SSell477$0.69329
2023-11-08Gaggar AnujBuy500.00K$0.85425.00K
2023-11-08Gaggar AnujOther0——
2023-10-23Schornstein AlexanderSell0——
2023-10-23Schornstein AlexanderOther0——
2023-10-16GILEAD SCIENCES, INC.Sell0——
2023-10-03White Nicole SSell1.89K$0.801.50K
2023-10-03Delaney William E IVSell1.89K$0.801.50K
2023-10-03Okazaki Jason ASell2.36K$0.801.88K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 97, holders +23 vs prior quarter. Ownership 99.60%.

HolderSharesChangeChange %Value
GILEAD SCIENCES, INC.4.98M471.70K+10.47%136.77M
FARALLON CAPITAL MANAGEMENT, L.L.C.1.60M377.00K+30.71%44.09M
PARADIGM BIOCAPITAL ADVISORS LP1.55M888.50K+133.56%42.70M
COMMODORE CAPITAL LP1.42M415.00K+41.50%38.88M
RA CAPITAL MANAGEMENT, L.P.1.02M00.00%28.04M
JUPITER TOPCO LLC849.31K849.31KNew23.37M
BLACKROCK, INC.766.82K564.08K+278.22%21.07M
PARKMAN HEALTHCARE PARTNERS LLC721.18K309.95K+75.37%19.82M
VANGUARD CAPITAL MANAGEMENT LLC558.94K68.50K+13.97%15.36M
POINT72 ASSET MANAGEMENT, L.P.460.59K116.49K+33.85%12.66M
SEVEN FLEET CAPITAL MANAGEMENT LP433.15K377.00K+671.45%11.90M
MILLENNIUM MANAGEMENT LLC298.81K65.16K+27.89%8.21M
GEODE CAPITAL MANAGEMENT, LLC280.42K147.45K+110.89%7.71M
SCHONFELD STRATEGIC ADVISORS LLC242.15K121.65K+100.96%6.65M
AMERIPRISE FINANCIAL INC230.00K230.00KNew6.32M
DV EQUITIES, LLC226.41K226.41KNew6.22M
ABERDEEN GROUP PLC207.05K207.05KNew5.69M
AFFINITY ASSET ADVISORS, LLC190.00K190.00KNew5.22M
B GROUP, INC.175.71K00.00%4.83M
STATE STREET CORP171.93K115.24K+203.29%4.72M
STEMPOINT CAPITAL LP170.38K-15.06K-8.12%4.68M
SQUADRON CAPITAL MANAGEMENT LLC160.00K160.00KNew4.40M
WOODLINE PARTNERS LP150.78K150.78KNew4.14M
DRIEHAUS CAPITAL MANAGEMENT LLC150.00K150.00KNew4.12M
ALLY BRIDGE GROUP (NY) LLC140.00K140.00KNew3.85M

Earnings and financials

Assembly Biosciences, Inc. (ASMB) trades at $20.44, with a market cap of $416.23M and a trailing P/E of 36.07. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
090187501480400015963000791050006254000071630002852000072303000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Assembly Biosciences (ASMB) Financials: Revenue & Earnings

ASMB$20.44+0.14 +0.70%

$416.23M

Market Cap

36.07

P/E

—

Forward P/E

63

Score

Price History